Global Orally Disintegrating Tablet Excipient Market Overview And Scope:
Global Orally Disintegrating Tablet Excipient Market Size was estimated at USD 16749.66 million in 2022 and is projected to reach USD 20631.43 million by 2028, exhibiting a CAGR of 3.53% during the forecast period.
The Global Orally Disintegrating Tablet Excipient Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Orally Disintegrating Tablet Excipient utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, McePharma (Vivesa holding), Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical
Global Orally Disintegrating Tablet Excipient Market Segmentation
By Type, Orally Disintegrating Tablet Excipient market has been segmented into:Binders
Glidents
Diluents
Disintegrants
Others
By Application, Orally Disintegrating Tablet Excipient market has been segmented into:
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Orally Disintegrating Tablet Excipient market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Orally Disintegrating Tablet Excipient market.
Top Key Players Covered in Orally Disintegrating Tablet Excipient market are:
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Objective to buy this Report:
1. Orally Disintegrating Tablet Excipient analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Orally Disintegrating Tablet Excipient market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Orally Disintegrating Tablet Excipient Market by Type
5.1 Orally Disintegrating Tablet Excipient Market Overview Snapshot and Growth Engine
5.2 Orally Disintegrating Tablet Excipient Market Overview
5.3 Binders
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Binders: Geographic Segmentation
5.4 Glidents
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Glidents: Geographic Segmentation
5.5 Diluents
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Diluents: Geographic Segmentation
5.6 Disintegrants
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Disintegrants: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
Chapter 6: Orally Disintegrating Tablet Excipient Market by Application
6.1 Orally Disintegrating Tablet Excipient Market Overview Snapshot and Growth Engine
6.2 Orally Disintegrating Tablet Excipient Market Overview
6.3 Anti-Psychotics Drug
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Anti-Psychotics Drug: Geographic Segmentation
6.4 Anti-Epileptics Drug
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Anti-Epileptics Drug: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Orally Disintegrating Tablet Excipient Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Orally Disintegrating Tablet Excipient Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Orally Disintegrating Tablet Excipient Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 BASF
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 JRS PHARMA
7.4 ROQUETTE
7.5 ABF INGREDIENTS
7.6 DFE PHARMA
7.7 EVONIK
7.8 MERCK KGAA
7.9 ASHLAND
7.10 MEGGLE PHARMA
7.11 SHIN-ETSU
7.12 FUJI CHEMICAL INDUSTRIES
7.13 MCEPHARMA (VIVESA HOLDING)
7.14 CARGILL INCORPORATED
7.15 DAICEL CORPORATION
7.16 ANHUI SUNHERE PHARMACEUTICAL
Chapter 8: Global Orally Disintegrating Tablet Excipient Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Binders
8.2.2 Glidents
8.2.3 Diluents
8.2.4 Disintegrants
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Anti-Psychotics Drug
8.3.2 Anti-Epileptics Drug
8.3.3 Others
Chapter 9: North America Orally Disintegrating Tablet Excipient Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Binders
9.4.2 Glidents
9.4.3 Diluents
9.4.4 Disintegrants
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Anti-Psychotics Drug
9.5.2 Anti-Epileptics Drug
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Orally Disintegrating Tablet Excipient Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Binders
10.4.2 Glidents
10.4.3 Diluents
10.4.4 Disintegrants
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Anti-Psychotics Drug
10.5.2 Anti-Epileptics Drug
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Orally Disintegrating Tablet Excipient Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Binders
11.4.2 Glidents
11.4.3 Diluents
11.4.4 Disintegrants
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Anti-Psychotics Drug
11.5.2 Anti-Epileptics Drug
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Orally Disintegrating Tablet Excipient Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Binders
12.4.2 Glidents
12.4.3 Diluents
12.4.4 Disintegrants
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Anti-Psychotics Drug
12.5.2 Anti-Epileptics Drug
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Orally Disintegrating Tablet Excipient Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Binders
13.4.2 Glidents
13.4.3 Diluents
13.4.4 Disintegrants
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Anti-Psychotics Drug
13.5.2 Anti-Epileptics Drug
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Orally Disintegrating Tablet Excipient Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Binders
14.4.2 Glidents
14.4.3 Diluents
14.4.4 Disintegrants
14.4.5 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Anti-Psychotics Drug
14.5.2 Anti-Epileptics Drug
14.5.3 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Orally Disintegrating Tablet Excipient Scope:
|
Report Data
|
Orally Disintegrating Tablet Excipient Market
|
|
Orally Disintegrating Tablet Excipient Market Size in 2025
|
USD XX million
|
|
Orally Disintegrating Tablet Excipient CAGR 2025 - 2032
|
XX%
|
|
Orally Disintegrating Tablet Excipient Base Year
|
2024
|
|
Orally Disintegrating Tablet Excipient Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, McePharma (Vivesa holding), Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.
|
|
Key Segments
|
By Type
Binders
Glidents
Diluents
Disintegrants
Others
By Applications
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
|
